In addition to TNBC, ERβ was found to decrease the invasiveness of inflammatory breast cancer (IBC) cells by downregulating GPR141 and the guanine nucleotide exchange factor (GEF)-interacting protein ELMO1 that activate the mediator of IBC metastasis RhoC [65]. This evidence concerns the gene GPR141 and inflammatory breast carcinoma.